Evidence map›Paper›PMID 22502561›Full record

ArticleJournal of biomedical optics2012

Wide-field spectral imaging of human ovary autofluorescence and oncologic diagnosis via previously collected probe data.

Timothy E Renkoski, Kenneth D Hatch, Urs Utzinger

Open access · bronzeAbstract read
In one paragraph

Article in Journal of biomedical optics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Single-Cell Analysis Using Hyperspectral Imaging Modalities.Journal of biomechanical engineering · 2018
    Review
  8. Article
  9. Article
  10. Medical hyperspectral imaging: a review.Journal of biomedical optics · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Timothy E RenkoskiUniversity of Arizona, College of Optical Sciences, 1630 East University Boulevard, Tucson, Arizona 85721, USA.
Kenneth D Hatch
Urs Utzinger
University of Arizona · US

Funding

Graduate Training in Biomedical Imaging SpectrocopyT32EB000809 · NIBIB · UNIVERSITY OF ARIZONA · PI GMITRO, ARTHUR F. · 2003 to 2018
$3.3M
Optical Spectroscopy of Ovarian CancerR01CA098341 · NCI · UNIVERSITY OF ARIZONA · PI UTZINGER, URS · 2003 to 2005
$915k
NCI NIH HHS R01 CA098341NCI NIH HHS R01CA098341NIBIB NIH HHS T32 EB000809NIBIB NIH HHS T32EB000809
6 · The paper itself

Abstract

With no sufficient screening test for ovarian cancer, a method to evaluate the ovarian disease state quickly and nondestructively is needed. The authors have applied a wide-field spectral imager to freshly resected ovaries of 30 human patients in a study believed to be the first of its magnitude. Endogenous fluorescence was excited with 365-nm light and imaged in eight emission bands collectively covering the 400- to 640-nm range. Linear discriminant analysis was used to classify all image pixels and generate diagnostic maps of the ovaries. Training the classifier with previously collected single-point autofluorescence measurements of a spectroscopic probe enabled this novel classification. The process by which probe-collected spectra were transformed for comparison with imager spectra is described. Sensitivity of 100% and specificity of 51% were obtained in classifying normal and cancerous ovaries using autofluorescence data alone. Specificity increased to 69% when autofluorescence data were divided by green reflectance data to correct for spatial variation in tissue absorption properties. Benign neoplasm ovaries were also found to classify as nonmalignant using the same algorithm. Although applied ex vivo, the method described here appears useful for quick assessment of cancer presence in the human ovary.

Indexed as

AlgorithmsCalibrationCase-Control StudiesDiagnostic ImagingDiscriminant AnalysisFemaleHumansImage Processing, Computer-AssistedMiddle AgedOvarian NeoplasmsOvarySensitivity and SpecificitySpectrometry, Fluorescence

Identifiers

PMID22502561
PMCPMC3380934
OpenAlexW2099004382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.